Innocrin Pharmaceuticals raised $28M Series D venture round, led by Fred Eshelman.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$28M
Top Valuation
-
Innocrin Pharmaceuticals raised $28M in a Series D round.
The round was announced on 04/14/15.
The round was led by Fred Eshelman.